Categories AlphaGraphs, Earnings, Health Care
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement.
The pharmaceutical company reported a 39% growth in fourth-quarter revenue of $11.1 billion, which surpassed Wall Street’s consensus forecast. Consequently, adjusted earnings rose 20% annually to $1.46 per share from $1.22 per share in the fourth quarter of 2019.
On an unadjusted basis, it was a net loss of $10.0 billion or $4.45 per share, compared to a loss of $1.1 billion or $0.55 per share last year.
Read management/analysts’ comments on Bristol Myers’ Q4 report
BMY shares gained 1% immediately after the announcement early Thursday. The stock had closed the previous session lower.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
